KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Receivables (2016 - 2026)

Teladoc Health's Receivables history spans 13 years, with the latest figure at $222.5 million for Q1 2026.

  • On a quarterly basis, Receivables fell 8.51% to $222.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $222.5 million, a 8.51% decrease, with the full-year FY2025 number at $201.7 million, down 9.96% from a year prior.
  • Receivables hit $222.5 million in Q1 2026 for Teladoc Health, up from $201.7 million in the prior quarter.
  • Over the last five years, Receivables for TDOC hit a ceiling of $243.2 million in Q1 2025 and a floor of $201.7 million in Q4 2025.
  • Historically, Receivables has averaged $226.3 million across 5 years, with a median of $227.3 million in 2022.
  • Biggest five-year swings in Receivables: grew 27.01% in 2022 and later dropped 9.96% in 2025.
  • Tracing TDOC's Receivables over 5 years: stood at $235.6 million in 2022, then dropped by 2.37% to $230.1 million in 2023, then dropped by 2.65% to $224.0 million in 2024, then dropped by 9.96% to $201.7 million in 2025, then rose by 10.35% to $222.5 million in 2026.
  • Business Quant data shows Receivables for TDOC at $222.5 million in Q1 2026, $201.7 million in Q4 2025, and $219.5 million in Q3 2025.